×
0 0 0 0 -0.0654292257340738 -0.0654292257340738 -0.0654292257340738 -0.119204131396201
Stock impact report

LogicBio up 20% ahead of IND filing for lead gene therapy candidate [Seeking Alpha]

LogicBio Therapeutics, Inc (LOGC)  More Company Research Source: Seeking Alpha
Last logicbio therapeutics, inc earnings: 8/13 08:00 am Check Earnings Report
PDF LogicBio up 20% ahead of IND filing for lead gene therapy candidate - LogicBio Therapeutics, Inc. (NASDAQ:LOGC) | Seeking Alpha Healthcare | LogicBio up 20% ahead of IND filing for lead gene therapy candidate Aug. 13, 2019 1:11 PM ET LogicBio Therapeutics,... (LOGC) Douglas W. House Ultra-thinly traded micro cap LogicBio Therapeutics ( +20% Q2 report It expects to file an IND next quarter for lead gene therapy candidate LB-001 methylmalonic acidemia Presuming FDA signoff on the filing, a natural history study will be initiated in Q4 followed by the launch of a Phase 1/2 clinical trial in H1 2020. Preliminary data may be available in H2 2020. See all stocks on the move » Now read: Unum Therapeutics (UMRX) Investor Presentation - Slideshow » Subscribe [Read more]
Impact snapshot Event time: LOGC
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
LOGC alerts
from News Quantified
Opt-in for
LOGC alerts

from News Quantified
Opt-in for
LOGC alerts

from News Quantified